| scholarly article | Q13442814 |
| P50 | author | Iago Pinal-Fernandez | Q55437081 |
| Maria Casal-Dominguez | Q87664088 | ||
| P2093 | author name string | Andrew L Mammen | |
| P2860 | cites work | Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis | Q26825582 |
| Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C- | Q27021322 | ||
| Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins | Q28574245 | ||
| Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy | Q30317429 | ||
| Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort | Q30792028 | ||
| Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy | Q33975216 | ||
| A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy | Q34520109 | ||
| Effect of microbial fermentation on content of statin, GABA, and polyphenols in Pu-Erh tea. | Q34690491 | ||
| Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia | Q34990271 | ||
| Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series | Q35021812 | ||
| Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin | Q35163067 | ||
| Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. | Q35632755 | ||
| Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology | Q35693060 | ||
| Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies | Q35824298 | ||
| The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy | Q35876136 | ||
| Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy | Q35909737 | ||
| Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness | Q36087017 | ||
| Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan | Q36153401 | ||
| Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects | Q36154282 | ||
| Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy | Q36239671 | ||
| Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy | Q37324573 | ||
| Human autoantibodies reactive with the signal-recognition particle | Q37411424 | ||
| Statin-Associated Autoimmune Myopathy | Q38737361 | ||
| Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study | Q38761660 | ||
| Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. | Q38948633 | ||
| Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. | Q38957797 | ||
| Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. | Q39824090 | ||
| A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. | Q40275221 | ||
| Anti-signal recognition particle myopathy in the first decade of life | Q40318231 | ||
| High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. | Q40795767 | ||
| Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. | Q42014200 | ||
| Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle | Q44218858 | ||
| Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. | Q45969468 | ||
| Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature | Q46895096 | ||
| Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity | Q48344148 | ||
| 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. | Q48540407 | ||
| Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis | Q49921821 | ||
| More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. | Q50948932 | ||
| Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies. | Q51199320 | ||
| Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. | Q51206969 | ||
| Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. | Q51527887 | ||
| The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis. | Q53319680 | ||
| Editorial: A New Classification of Adult Autoimmune Myositis. | Q53375302 | ||
| Inflammatory Muscle Diseases. | Q53413461 | ||
| Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. | Q54470882 | ||
| Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. | Q55070100 | ||
| 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
| HLA-DRB1 alleles in immune-mediated necrotizing myopathy: Table 1 | Q58036079 | ||
| Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies | Q61762709 | ||
| Antibody to signal recognition particle in polymyositis | Q61762714 | ||
| A novel antibody which precipitates 7.5S RNA is isolated from a patient with autoimmune disease | Q71482963 | ||
| Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies | Q77944564 | ||
| Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis | Q84458729 | ||
| Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral ne | Q85170003 | ||
| Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy | Q86335291 | ||
| Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms | Q86428125 | ||
| Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy | Q88013139 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 21 | |
| P577 | publication date | 2018-03-26 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Immune-Mediated Necrotizing Myopathy. | |
| P478 | volume | 20 |
| Q58617501 | A child with antibody negative immune-mediated necrotizing myopathy |
| Q61796905 | Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report |
| Q89835389 | Autoantibody Biomarkers in Rheumatic Diseases |
| Q94086766 | Diabetic myonecrosis: an uncommon diabetic complication |
| Q97521440 | Immune mediated necrotizing myopathy: A rare complication of statin therapy |
| Q99403781 | Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum |
| Q92735089 | Secondary cardiac involvement in anti-SRP-antibody-positive myopathy: an 87-year-old woman with heart failure symptoms as the first clinical presentation |
| Q92155590 | Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment |
| Q92156926 | Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components |
| Q90647761 | The spectrum of idiopathic inflammatory myopathies in South Africa |
Search more.